These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia. Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091 [No Abstract] [Full Text] [Related]
10. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808 [No Abstract] [Full Text] [Related]
11. Chronic granulocytic leukaemia. A study of 160 cases. Kumar L; Sagar TG; Maitreyan V; Majhi U; Shanta V J Assoc Physicians India; 1990 Dec; 38(12):899-902. PubMed ID: 2096123 [TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib. Fang B; Song Y; Han Z; Wei X; Lin Q; Zhu X; Yang R; Sun J; Tian G; Liu X; Cao G; Shi Y; Nie N; Li D; Zhao RC Leuk Res; 2007 Oct; 31(10):1441-4. PubMed ID: 17383001 [TBL] [Abstract][Full Text] [Related]
13. Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia. Maia RC; Noronha H; Vasconcelos FC; Rumjanek VM Clin Lab Haematol; 1997 Sep; 19(3):215-7. PubMed ID: 9352149 [TBL] [Abstract][Full Text] [Related]
15. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study. Meloni G; Foà R; Tosti S; Vignetti M; Gavosto F; Mandelli F Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290 [TBL] [Abstract][Full Text] [Related]
16. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208 [TBL] [Abstract][Full Text] [Related]
17. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis. Fruehauf S; Topaly J; Buss EC; Fischer T; Ottmann OG; Emmerich B; Müller MC; Schuld P; Balleisen L; Hehlmann R; Ho AD; Hochhaus A Cancer; 2007 Apr; 109(8):1543-9. PubMed ID: 17340589 [TBL] [Abstract][Full Text] [Related]
18. Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia. Breccia M; Serrao A; Salaroli A; Loglisci G; Zacheo I; Alimena G Br J Haematol; 2012 Dec; 159(5):612-3. PubMed ID: 23043319 [No Abstract] [Full Text] [Related]
19. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis. Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302 [TBL] [Abstract][Full Text] [Related]
20. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia. Honda H; Miyagawa K; Endo M; Takaku F; Yazaki Y; Hirai H Int J Hematol; 1993 Jun; 57(3):221-7. PubMed ID: 8364186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]